Company Filing History:
Years Active: 2025
Title: Felix Bock: Innovator in Ocular Treatment
Introduction
Felix Bock is a notable inventor based in Cologne, Germany. He has made significant contributions to the field of ophthalmology, particularly in the treatment of ocular neovascularization. His innovative work has led to the development of a unique ophthalmic composition that addresses critical medical needs.
Latest Patents
Felix Bock holds a patent for "Compositions and methods for the treatment of ocular neovascularization." This invention relates to a non-aqueous ophthalmic composition that comprises particles of a protein powder preparation suspended in a liquid vehicle made of a semifluorinated alkane. The particles contain an anti-VEGF protein, specifically aflibercept or a sequence with at least 90% sequence identity to SEQ ID NO: 1. This composition is particularly effective for treating ocular neovascularization.
Career Highlights
Felix Bock is associated with Novaliq GmbH, a company that focuses on innovative ophthalmic therapies. His work at Novaliq has been instrumental in advancing treatment options for patients suffering from eye diseases. With a patent portfolio that includes 1 patent, he continues to push the boundaries of medical science.
Collaborations
Felix collaborates with esteemed colleagues such as Madlen Witt and Claus Cursiefen. Their combined expertise enhances the research and development efforts at Novaliq, fostering an environment of innovation and discovery.
Conclusion
Felix Bock's contributions to ocular treatment exemplify the impact of innovation in medicine. His patented work not only addresses significant health challenges but also showcases the potential of collaborative efforts in advancing medical science.